Ramona Doyle - 04 Feb 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Medical Officer
Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
04 Feb 2022
Net transactions value
-$11,183
Form type
4
Filing time
08 Feb 2022, 20:09:45 UTC
Previous filing
02 Feb 2022
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +38,499 +67% $0.000000 95,834 04 Feb 2022 Direct F1
transaction RXRX Class A Common Stock Award $0 +2,392 +2.5% $0.000000 98,226 04 Feb 2022 Direct F2
transaction RXRX Class A Common Stock Tax liability $11,183 -981 -1% $11.40 97,245 04 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Award $0 +76,998 $0.000000 76,998 04 Feb 2022 Class A Common Stock 76,998 $11.40 Direct F3
transaction RXRX Stock Option (Right to Buy) Award $0 +4,784 $0.000000 4,784 04 Feb 2022 Class A Common Stock 4,784 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 694,053 04 Feb 2022 Class A Common Stock 694,053 $2.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter.
F2 This RSU vested immediately upon the grant date.
F3 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F4 Twenty-Five percent (25%) of the 750,000 shares originally subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.